当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析 - 利润表

金城医药

(300233)

  

流通市值:62.38亿  总市值:64.68亿
流通股本:3.70亿   总股本:3.84亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入2,568,752,667.571,705,293,296.69829,526,5423,505,716,962.18
营业收入2,568,752,667.571,705,293,296.69829,526,5423,505,716,962.18
二、营业总成本2,386,749,531.41,570,483,289.96765,199,920.753,133,449,189.56
营业成本1,481,237,371.13969,720,965.31475,423,314.441,885,255,703.98
税金及附加28,097,165.9218,305,243.489,061,715.2833,050,462.73
销售费用489,839,831.89315,565,703.59150,312,138.72628,591,714.07
管理费用256,459,465.98184,252,986.4593,935,166.62400,743,135.52
研发费用121,823,184.3676,204,151.7428,502,407.61171,103,542.54
财务费用9,292,512.126,434,239.397,965,178.0814,704,630.72
其中:利息费用19,192,178.5913,470,866.876,674,810.4826,824,004.62
其中:利息收入9,442,987.346,048,361.313,326,254.1912,255,352.25
加:公允价值变动收益-13,411.7-264,453.95-334,685.44-483,566.67
加:投资收益-70,366.52-333,115.14-16,391.913,444,211.06
资产处置收益-2,611,874.47-2,840,726.18-374,726.611,525,259.74
资产减值损失(新)-18,541,487.6-7,484,141.49-48,413.87-40,769,711.81
信用减值损失(新)-1,839,142.59-987,392.27-1,405,326.19-1,331,591.31
其他收益16,589,485.4711,274,006.56,600,474.5719,124,902.48
营业利润平衡项目0000
四、营业利润175,516,338.76134,174,184.268,747,551.8353,777,276.11
加:营业外收入773,540.77725,990.63654,021.975,657,679.6
减:营业外支出-11,497.86-792,177.72-835,148.413,468,969.31
利润总额平衡项目0000
五、利润总额176,301,377.39135,692,352.5570,236,722.17345,965,986.4
减:所得税费用29,646,354.2124,919,791.715,357,053.260,091,754.74
六、净利润146,655,023.18110,772,560.8554,879,668.97285,874,231.66
持续经营净利润146,655,023.18110,772,560.8554,879,668.97285,874,231.66
归属于母公司股东的净利润132,480,355.98101,709,417.1350,154,655.33273,364,594
少数股东损益14,174,667.29,063,143.724,725,013.6412,509,637.66
(一)基本每股收益0.340.260.130.71
(二)稀释每股收益0.340.260.130.71
八、其他综合收益7,056,674.17,056,674.15,511,232.38-
归属于母公司股东的其他综合收益7,056,674.17,056,674.15,511,232.38-
九、综合收益总额153,711,697.28117,829,234.9560,390,901.35285,874,231.66
归属于母公司股东的综合收益总额139,537,030.08108,766,091.2355,665,887.71273,364,594
归属于少数股东的综合收益总额14,174,667.29,063,143.724,725,013.6412,509,637.66
公告日期2023-10-252023-08-192023-04-272023-03-31
审计意见(境内)标准无保留意见
TOP↑